Gifford Pediatric and Adolescent Medicine Recognized for Teen HPV Vaccination Rates

News Release

For Immediate Release: December 28, 2018

Media Contacts:
Ben Truman, Vermont Department of Health
802-951-5153 / 802-863-7281 bennett.truman@vermont.gov

Maryellen Apelquist, Gifford Health Care
802-728-2284 mapelquist@giffordmed.org

 

Gifford Pediatric and Adolescent Medicine Recognized for Teen HPV Vaccination Rates

Gifford Pediatric and Adolescent Medicine in Randolph has been named a 2018 HPV Vaccine-is-Cancer-Prevention Champion for its outstanding effort to protect adolescents from cancers caused by human papillomavirus (HPV). The Centers for Disease Control and Prevention, Association of American Cancer Institutes and the American Cancer Society selected Gifford in recognition for its high rates of HPV vaccination.

The national award program recognizes clinicians, clinics, practices, groups and health systems that are leaders in their communities in fostering HPV vaccination. This year, the award program is honoring champions from 32 states, including Gifford in Vermont.

HPV is a virus that can cause six different types of cancer. It is so common that nearly all sexually active men and women get it at some point in their lives. Nearly 80 million people are currently infected in the United States, and every year 33,700 men and women are diagnosed with a cancer caused by HPV infection. There are many different types of HPV. Some types can cause health problems, including genital warts and cancers.

Gifford’s achievement is all the more important because 70 to 90 percent of cancers caused by HPV can be prevented by the HPV vaccine. In addition, the vaccine prevents most common health problems associated with the virus. To provide as much protection as possible, public health officials recommend that all adolescents and young adults be vaccinated against HPV beginning at age 11.

Gifford Pediatric and Adolescent Medicine implemented an HPV Quality Improvement Project in 2016 to increase the number of adolescents who receive the recommended doses of HPV vaccine. Currently, 81 percent of the practice’s patients age 13 to 17 years have received the recommended doses of HPV vaccine, which is higher than the state and national averages.

To see Gifford Pediatric and Adolescent Medicine’s profile and learn more about the HPV-Vaccine-is-Cancer-Prevention Champion Award program, visit cdc.gov/hpv.

Learn more about HPV and other recommended vaccinations for teens and young adults: healthvermont.gov/immunizations-infectious-disease/immunization/parents.

For health news, alerts and information, visit healthvermont.gov
Join us on Facebook
Follow us on Twitter

# # #